A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis

In the last 40 years, only a single new antituberculosis drug was FDA approved. New tools that improve the drug development process will be essential to accelerate the development of next-generation antituberculosis drugs. The drug development process seems to be hampered by the inefficient transiti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Assay Drug Dev Technol
Main Authors: Schaaf, Kaitlyn, Hayley, Virginia, Speer, Alexander, Wolschendorf, Frank, Niederweis, Michael, Kutsch, Olaf, Sun, Jim
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4991579/
https://ncbi.nlm.nih.gov/pubmed/27327048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/adt.2016.717
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados